WC Bioscience Accelerator Participants

Co-Nexi Vision
Cyril Eleftheriou
Cyril has an artificial dopaminergic neuron for treating light-adaptation deficits in the retinas of patients with dystrophic retinal conditions, including night-blindness.
Co-Nexi Vision
Cyril has an artificial dopaminergic neuron for treating light-adaptation deficits in the retinas of patients with dystrophic retinal conditions, including night-blindness.